← Evidence map

ReviewExpert opinion on drug metabolism & toxicology2025

Pharmacotherapy in kidney disease: what it takes to move from general guidance to specific recommendations to stratified subgroups of patients - the tale of autosomal dominant polycystic kidney disease (ADPKD).

Annika C Tillmann et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

Not cited yet

Pharmacotherapy in kidney disease: what it takes to move from general guidance to specific recommendations to stratified subgroups of patients - the tale of autosomal dominant polycystic kidney disease (ADPKD). | OpenQuestion